Home LiteratureArticle Details
PMID: 8949657 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages.

Gut ·Vol. 39 ·No. 3 ·1996-09-00 ·Pages 475-8

Ljubuncic P, Fuhrman B, Oiknine J, Aviram M, Bomzon A

Abstract

Kupffer cells are essential for normal hepatic homeostasis and when stimulated, they secrete reactive oxygen species, nitric oxide, eicosanoids, and cytokines. Some of these products are cytotoxic and attack nucleic acids, thiol proteins, or membrane lipids causing lipid peroxidation. Hydrophobic bile acids, such as deoxycholic acid (DCA), can damage hepatocytes by solubilising membranes and impairing mitochondrial function, as well as increasing the generation of reactive oxygen species. The hypothesis that hydrophobic bile acids could stimulate Kupffer cells to increase their capacity to generate reactive oxygen species by measuring cellular lipid peroxidation was tested. Because the hydrophilic bile acid, ursodeoxycholic acid (UDCA) can block hydrophobic bile acid induced cellular phenomena, it was also hypothesised that UDCA could antagonise macrophage activation by hydrophobic bile acids to blunt their capacity to generate reactive oxygen species. J-774A.1 murine macrophages were incubated for 24 hours with either 10(-5) M and 10(-4) M (final concentration) DCA alone, or 10(-4) M UDCA alone, or a mixture of 10(-4) M 1:1 molar ratio of DCA and UDCA. At the end of the incubation period, the culture medium was collected for determination of cellular lipid peroxidation by measuring the malondialdehyde (MDA) content in the medium with the thiobarbituric acid reactive substances assay. 10(-5) M and 10(-4) M DCA increased MDA generation by cultured macrophages. 10(-4) M UDCA alone did not increase MDA generation but blocked the peroxidative actions of DCA. Hydrophobic bile acids, after their hepatic retention, can oxidatively activate Kupffer cells to generate reactive oxygen species. Because UDCA can block this action, the beneficial effect of UDCA is, in part, related to its ability to act as an antioxidant.

MeSH Terms
Animals Cell Culture Techniques Deoxycholic Acid/antagonists & inhibitors,pharmacology Lipid Peroxidation/drug effects Macrophage Activation/drug effects Macrophages/drug effects,metabolism Mice Ursodeoxycholic Acid/pharmacology
Chemicals
Deoxycholic Acid Ursodeoxycholic Acid
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ljubuncic P
Department of Pharmacology, Technion-Israel Institute of Technology, Haifa.
Fuhrman B
Oiknine J
Aviram M
Bomzon A
References (40)
40 references, click to expand
  1. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.
    Hepatology. 1990 Sep;12(3 Pt 1):492-7 PMID: 2401455
  2. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.
    Proc Natl Acad Sci U S A. 1990 Feb;87(4):1620-4 PMID: 2154753
  3. Malondialdehyde determination as index of lipid peroxidation.
    Methods Enzymol. 1990;186:421-31 PMID: 2233309
  4. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.
    Gastroenterology. 1991 Jan;100(1):203-11 PMID: 1983822
  5. A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis.
    Gastroenterol Jpn. 1990 Dec;25(6):774-80 PMID: 1980654
  6. Hypercholeresis induced by unconjugated bile acid infusion correlates with recovery in bile of unconjugated bile acids.
    Hepatology. 1991 Mar;13(3):540-50 PMID: 1999323
  7. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
    N Engl J Med. 1991 May 30;324(22):1548-54 PMID: 1674105
  8. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.
    Hepatology. 1991 Dec;14(6):1000-7 PMID: 1959845
  9. Mechanism of bile acid-induced HCO3-(-)rich hypercholeresis. An analysis based on quantitative acid-base chemistry.
    J Hepatol. 1992 Jan;14(1):118-26 PMID: 1737911
  10. Immunomodulatory effects of ursodeoxycholic acid on immune responses.
    Hepatology. 1992 Aug;16(2):358-64 PMID: 1639344
  11. Reaction of nitric oxide with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide-mediated killing.
    FEBS Lett. 1993 Apr 19;321(1):59-62 PMID: 8385630
  12. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes.
    Hepatology. 1993 May;17(5):869-81 PMID: 8387948
  13. Molecular aspects of membrane stabilization by ursodeoxycholate [see comment].
    Gastroenterology. 1993 Jun;104(6):1736-44 PMID: 8388838
  14. Hepatoprotective properties of ursodeoxycholic acid.
    Gastroenterology. 1993 Jun;104(6):1865-70 PMID: 8500748
  15. The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells.
    Hepatology. 1993 Jul;18(1):165-72 PMID: 8325607
  16. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium.
    J Clin Invest. 1993 Jul;92(1):17-24 PMID: 8325981
  17. Measuring free radical reactions in vivo.
    Br Med Bull. 1993 Jul;49(3):494-505 PMID: 8221018
  18. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.
    Gastroenterology. 1994 Jan;106(1):134-42 PMID: 8276175
  19. Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.
    N Engl J Med. 1994 May 12;330(19):1342-7 PMID: 8152446
  20. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.
    Gastroenterology. 1994 May;106(5):1284-90 PMID: 8174890
  21. Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts.
    Gastroenterology. 1994 May;106(5):1333-41 PMID: 8174892
  22. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Hepatology. 1994 May;19(5):1149-56 PMID: 8175136
  23. Ursodeoxycholic acid and primary biliary cirrhosis.
    BMJ. 1994 Aug 20-27;309(6953):491-2 PMID: 8086896
  24. Ursodeoxycholate-induced hypercholeresis in cirrhotic rats: further evidence for cholehepatic shunting.
    Hepatology. 1994 Oct;20(4 Pt 1):1048-54 PMID: 7927207
  25. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria.
    Hepatology. 1994 Dec;20(6):1595-601 PMID: 7982660
  26. Liver cell necrosis: cellular mechanisms and clinical implications.
    Gastroenterology. 1995 Jan;108(1):252-75 PMID: 7806049
  27. Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis.
    J Hepatol. 1994 Oct;21(4):624-33 PMID: 7814810
  28. Pharmacology of ursodeoxycholic acid, an enterohepatic drug.
    Scand J Gastroenterol Suppl. 1994;204:1-15 PMID: 7824870
  29. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties.
    Atherosclerosis. 1994 Nov;111(1):65-78 PMID: 7840815
  30. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.
    J Pharmacol Exp Ther. 1995 Feb;272(2):930-8 PMID: 7853211
  31. Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children.
    Pharmacol Ther. 1995 Apr;66(1):1-15 PMID: 7630925
  32. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  33. Biology of disease: free radicals and tissue injury.
    Lab Invest. 1982 Nov;47(5):412-26 PMID: 6290784
  34. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
    Lancet. 1987 Apr 11;1(8537):834-6 PMID: 2882236
  35. Relationship of bile salt stimulation of colonic epithelial phospholipid turnover and proliferative activity: role of activation of protein kinase C1.
    Prev Med. 1987 Jul;16(4):572-9 PMID: 3628203
  36. Current concepts: immunology. Monocytes and macrophages.
    N Engl J Med. 1988 Mar 24;318(12):747-52 PMID: 3279314
  37. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions.
    J Lipid Res. 1989 May;30(5):719-30 PMID: 2760545
  38. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
    Gut. 1989 Aug;30(8):1110-5 PMID: 2767508
  39. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial.
    Gastroenterology. 1989 Nov;97(5):1268-74 PMID: 2551765
  40. Hepatic injury induced by bile salts: correlation between biochemical and morphological events.
    Hepatology. 1990 Nov;12(5):1216-21 PMID: 2227821
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
Published
1996-09-00
Pages
475-8
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC1383359
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]